173 related articles for article (PubMed ID: 19520790)
1. Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1.
van der Lee MM; Blomenröhr M; van der Doelen AA; Wat JW; Smits N; Hanson BJ; van Koppen CJ; Zaman GJ
J Biomol Screen; 2009 Aug; 14(7):811-23. PubMed ID: 19520790
[TBL] [Abstract][Full Text] [Related]
2. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
3. Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors.
Soethoudt M; van Gils N; van der Stelt M; Heitman LH
Methods Mol Biol; 2016; 1412():103-11. PubMed ID: 27245896
[TBL] [Abstract][Full Text] [Related]
4. Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Gαi signaling, and receptor internalization.
Berchiche YA; Gravel S; Pelletier ME; St-Onge G; Heveker N
Mol Pharmacol; 2011 Mar; 79(3):488-98. PubMed ID: 21088225
[TBL] [Abstract][Full Text] [Related]
5. CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity.
Baillie GL; Horswill JG; Anavi-Goffer S; Reggio PH; Bolognini D; Abood ME; McAllister S; Strange PG; Stephens GJ; Pertwee RG; Ross RA
Mol Pharmacol; 2013 Feb; 83(2):322-38. PubMed ID: 23160940
[TBL] [Abstract][Full Text] [Related]
6. Characterization of structurally novel G protein biased CB
Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL
Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808
[TBL] [Abstract][Full Text] [Related]
7. Kappa opioid receptor screen with the Tango beta-arrestin recruitment technology and characterization of hits with second-messenger assays.
Doucette C; Vedvik K; Koepnick E; Bergsma A; Thomson B; Turek-Etienne TC
J Biomol Screen; 2009 Apr; 14(4):381-94. PubMed ID: 19403921
[TBL] [Abstract][Full Text] [Related]
8. Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1.
Flores-Otero J; Ahn KH; Delgado-Peraza F; Mackie K; Kendall DA; Yudowski GA
Nat Commun; 2014 Aug; 5():4589. PubMed ID: 25081814
[TBL] [Abstract][Full Text] [Related]
9. Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands.
Leduc M; Breton B; Galés C; Le Gouill C; Bouvier M; Chemtob S; Heveker N
J Pharmacol Exp Ther; 2009 Oct; 331(1):297-307. PubMed ID: 19584306
[TBL] [Abstract][Full Text] [Related]
10. Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter beta-arrestin assay.
McGuinness D; Malikzay A; Visconti R; Lin K; Bayne M; Monsma F; Lunn CA
J Biomol Screen; 2009 Jan; 14(1):49-58. PubMed ID: 19171920
[TBL] [Abstract][Full Text] [Related]
11. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.
Ahn KH; Mahmoud MM; Kendall DA
J Biol Chem; 2012 Apr; 287(15):12070-82. PubMed ID: 22343625
[TBL] [Abstract][Full Text] [Related]
12. G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors.
Verkaar F; van Rosmalen JW; Blomenröhr M; van Koppen CJ; Blankesteijn WM; Smits JF; Zaman GJ
Biotechnol Annu Rev; 2008; 14():253-74. PubMed ID: 18606367
[TBL] [Abstract][Full Text] [Related]
13. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
Conroy JL; Free RB; Sibley DR
ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor.
Bosier B; Hermans E; Lambert D
Br J Pharmacol; 2008 Sep; 155(1):24-33. PubMed ID: 18536748
[TBL] [Abstract][Full Text] [Related]
16. Beta-arrestin-based Bret2 screening assay for the "non"-beta-arrestin binding CB1 receptor.
Vrecl M; Nørregaard PK; Almholt DL; Elster L; Pogacnik A; Heding A
J Biomol Screen; 2009 Apr; 14(4):371-80. PubMed ID: 19403920
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Biased β-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor.
Delgado-Peraza F; Ahn KH; Nogueras-Ortiz C; Mungrue IN; Mackie K; Kendall DA; Yudowski GA
Mol Pharmacol; 2016 Jun; 89(6):618-29. PubMed ID: 27009233
[TBL] [Abstract][Full Text] [Related]
18. Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB
Ryalls B; Patel M; Sparkes E; Banister SD; Finlay DB; Glass M
Biochem Pharmacol; 2024 Apr; 222():116052. PubMed ID: 38354957
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence.
Ibsen MS; Finlay DB; Patel M; Javitch JA; Glass M; Grimsey NL
Front Pharmacol; 2019; 10():350. PubMed ID: 31024316
[TBL] [Abstract][Full Text] [Related]
20. Cellular Assay to Study β-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2.
Bouma J; Soethoudt M; van Gils N; Xia L; van der Stelt M; Heitman LH
Methods Mol Biol; 2023; 2576():189-199. PubMed ID: 36152187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
